BNC Korea Co., Ltd. (KOSDAQ:256840)
South Korea · Delayed Price · Currency is KRW 3,735.00
+30.00 (0.81%)
Apr 10, 2026, 3:30 PM KST
BNC Korea Revenue
In the year 2025, BNC Korea had annual revenue of 95.90B KRW with 7.47% growth. BNC Korea had revenue of 23.57B in the quarter ending December 31, 2025, a decrease of -8.58%.
Revenue
95.90B
Revenue Growth
+7.47%
P/S Ratio
2.64
Revenue / Employee
383.60M
Employees
250
Market Cap
253.40B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 95.90B | 6.67B | 7.47% |
| Dec 31, 2024 | 89.23B | 8.23B | 10.16% |
| Dec 31, 2023 | 81.00B | 38.69B | 91.47% |
| Dec 31, 2022 | 42.30B | 17.05B | 67.55% |
| Dec 31, 2021 | 25.25B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| JW Holdings | 969.57B |
| Chong Kun Dang Holdings | 959.01B |
| Huons | 620.77B |
| Daewon Pharmaceutical | 605.43B |
| Samjin Pharmaceuticals | 274.03B |
| Ilyang Pharmaceutical Co.,Ltd | 272.42B |
| HLB Pharmaceutical | 205.58B |
| Boditech Med | 162.09B |